Kanaph, Imbiologics to kick off 2026 Korea biotech, med-tech IPOs

Lab-DirectCardiovascular Pacing and ICD Leads Price in Northern America - Market Insights - IndexBox

Merck KGaAMerck KGaA Backs Hybrid Cancer Drugs And Greener Lab Consumables - simplywall.st

BioPharma DiveArvinas’ ‘Protac’ breast cancer drug cleared by FDA

Clinical OMICsData-Driven Tool Identifies Individuals at Highest Risk of Obesity-Related Disease

Clinical OMICsMachine Learning Tool Helps Improve Type 1 Diabetes Prediction

Clinical OMICsPatient-Derived Lab-on-a-Chip Improves Precision Modeling of Pancreatic Cancer

Clinical OMICsCitraconate Enhances Antitumor Activity and Reduces Exhaustion in T Cells

Endpoints NewsModerna in talks with FDA over Phase 4 Covid vaccine data

Bio-RadBio-Rad Weighs 2026 Outlook As Middle East Headwinds Meet Stilla Hopes - simplywall.st

Endpoints NewsFDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data

ModernaModerna’s first quarter 2026 sales well ahead of estimates - The Pharma Letter

Endpoints NewsAmgen launches late-stage obesity trial in patients who switch from rival drugs